Insulin formulation and delivery.
Brange
J
J
Novo Nordisk A/S, Bagsvaerd, Denmark.
Langkjaer
L
L
D000595:Amino Acid Sequence; D001682:Biological Availability; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004333:Drug Administration Routes; D004339:Drug Compounding / Q000379:methods*; D016503:Drug Delivery Systems; D004355:Drug Stability; D006801:Humans; D007328:Insulin / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D007332:Insulin Infusion Systems; D008969:Molecular Sequence Data
D003692:Delayed-Action Preparations; D007328:Insulin